Authors
Latest:
Exploring sustained drug delivery options in ophthalmologyCurrent options, challenges in developing novel therapies.
Latest:
Modern monitoring strategies remove major barriers to retina careAnat Loewenstein, MD, presented real-world results of remote imaging at the International SPECTRALIS Symposium
Latest:
Retinal imaging to detect Alzheimer disease: machine learning modelAn interdisciplinary team at Duke University has developed a proof-of-concept machine learning model capable of detecting symptomatic Alzheimer disease using multimodal retinal imaging data.
Latest:
Sheng Lim, MD, FRCOphth, brings data from the CONCEPT study to the ASCRS meetingEndoscopic cyclophotocoagulation (ECP) has major potential for patients with glaucoma
Latest:
Evaluation of an enhanced monofocal intraocular lensThree IOLs are evaluated in a randomised study
Latest:
Clinicians keep their eyes on wartime ocular traumaEvery day brings a new challenge for surgeons in low-resource areas and conflict zones
Latest:
Balancing the promises and challenges of artificial intelligenceSophisticated programmes require an evolving mindset
Latest:
Reconfiguring treatment goals for paediatric myopia around ocular developmentConsidering ages and stages of myopia progression in a therapeutic timeline
Latest:
A new treatment paradigm with ab-interno canaloplasty for POAGWith minimally invasive surgery procedures becoming increasingly popular in glaucoma management, canaloplasty using an ab-interno surgical technique offers enhanced natural aqueous outflow in open-angle glaucoma.
Latest:
The relationship between myopia and conjunctival-scleral geometryA recent prospective study analysed the relationship between corneo-scleral geometry and the axial length of the eye to develop preliminary prediction models of the axial length of the eye based on clinical data.
Latest:
Inherited retinal diseases and gene therapies: A pharmaceutical overviewFor retinal specialists grappling with diseases once thought “untreatable,” gene therapies present a wide range of viable options
Latest:
Cellular evidence of retinal ganglion cell transfection after LHON treatmentData show transfection in both eyes despite unilateral injection
Latest:
Myopia’s global impact, by the numbersThe global prevalence of myopia has surged, and is expected to affect nearly 5 billion people by 2050
Latest:
Evaluating the clinical performance of ZEISS AT ELANA and the new ’ELISA’* approachIn this insightful analysis, Dr. Joong Hun Kim presents real-world clinical outcomes with bilateral implantation of ZEISS AT ELANA 841P. Dr. Kim recommends AT ELANA® 841P as an excellent option for patients undergoing cataract surgery as its fully trifocal optical design translates into a full range of vision. He also introduces the so-called ‘ELISA’ approach for patients requiring astigmatic correction in one eye only, combining AT ELANA 841P and ZEISS AT LISA tri toric 939MP. Early objective and subjective clinical data from this novel approach reveal promising visual outcomes and high patient satisfaction
Latest:
The rationale for enabling nurses to inject dexamethasone implantsNurses and other allied healthcare professionals can safely and effectively deliver intravitreal steroid implants in a clean room setting, which has reduced patient waiting times.
Latest:
Assessing the quality of real-world evidence in retinal diseasesA recently developed tool can help ophthalmologists to assess the quality of findings from real-world studies in retinal diseases. This will help them decide which results are most robust and applicable to their practice.
Latest:
Using swept-source OCT and OCT angiography to image choroidal tumoursSS-OCT provides a clear view of the eye’s internal structures and any abnormalities, helping to differentiate benign from malignant lesions.
Latest:
Ophthalmology and the climate crisis: Time to take responsibilityThe healthcare sector has high greenhouse gas emissions, to which ophthalmology is a significant contributor. Reducing waste, reusing instruments and medication and increasing our use of telemedicine can all contribute to reducing the carbon footprint of our specialty.
Latest:
ESCRS 2023: Presbyopia treatment with microporation therapeutic technology by Ace Vision GroupAnnMarie Hipsley, DPT, PhD, met with Ophthalmology Times Europe to discuss Ace Vision Group's microporation therapeutic technology, used to treat presbyopia.
Latest:
Small-aperture IOL yields high satisfaction in retrospective reviewThe IC-8 IOL uses the small-aperture concept to extend cataract patients’ depth of focus. Patients report high approval and reduced spectacle dependence.
Latest:
It takes a village to beat visual system diseases in childrenCommunity support is the most important factor in ascertaining effective treatments for paediatric eye diseases.
Latest:
My first experiences with AT ELANA 841P and ARTEVO 850This article by Liem Trinh, MD highlights his experiences with the AT ELANA® 841P hydrophobic trifocal IOL and the ARTEVO® 750 and ARTEVO® 850 microscopes from ZEISS. Dr. Trinh discusses the benefits of the trifocal design of the AT ELANA 841P IOL and its ability to provide spectacle independence at all distances after cataract surgery. He also shares his positive experiences with the ARTEVO 850 microscope, which offers improved surgical visualization with RGB LED illumination and 3D viewing on a high dynamic range monitor. Additionally, Dr. Trinh discusses the potential benefits of integrated intraoperative optical coherence tomography (OCT) and the redesigned CALLISTO eye user interface.
Latest:
The truth about invisible posterior vitreous structuresUnderstanding vitreomacular interface diseases is key to treatment.
Latest:
Adapting our understanding of cerebral visual impairmentThe differential recruitment of the dorsal and ventral visual streams
